BB Biotech AG reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2017. For the quarter, the company reported net loss of CHF 156 million compared to last year's loss of CHF 24 million. For the full year, the company reported net gain of CHF 688 million compared to a net loss of CHF 802 million for full year 2016.